Cas:1385694-74-5 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid manufacturer & supplier

Chemical Name:1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid

CAS.NO:1385694-74-5

Synonyms:1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid

Molecular Formula:C₁₃H₁₂BrClO₃

Molecular Weight:331.59000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:54.37000

Exact Mass:329.96600

LogP:3.56800

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid Use and application,1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid technical grade,usp/ep/jp grade.

Related News: Javier Valero-Elizondo, M.D., M.P.H., from the Houston Methodist DeBakey Heart and Vascular Center in Texas, and colleagues compared FT for individuals with ASCVD only, cancer only, both ASCVD and cancer, and neither ASCVD nor cancer using data from the National Health Interview Survey. 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid supplier ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States. 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid vendor RELATED: CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more 1-(2-Bromo-5-chlorophenyl)-4-oxocyclohexanecarboxylic acid factory Javier Valero-Elizondo, M.D., M.P.H., from the Houston Methodist DeBakey Heart and Vascular Center in Texas, and colleagues compared FT for individuals with ASCVD only, cancer only, both ASCVD and cancer, and neither ASCVD nor cancer using data from the National Health Interview Survey.